Updated Mar 23, 2026 by Nagase Brothers
Financial · May 1, 2025
Published by Nagase Brothers
Nagase Brothers Inc. reported its consolidated financial results for the fiscal year ended March 31, 2025, reflecting a period of growth in top-line revenue alongside a contraction in bottom-line profitability. The company achieved net sales of 55,255 million yen, representing a 4.3% increase over the previous fiscal year. Operating profit also saw positive momentum, rising 7.2% to 4,864 million yen. However, profit attributable to owners of the parent declined by 24.8% to 1,956 million yen, and ordinary profit fell by 10.3% to 3,879 million yen, resulting in basic earnings per share of 74.33 yen. The company’s financial position strengthened during the period, with total assets reaching 90,107 million yen and net assets rising to 31,172 million yen. The equity-to-asset ratio improved to 34.6%, up from 32.6% in the prior year. Cash flow dynamics shifted significantly, with operating activities generating 8,183 million yen, while investing and financing activities saw outflows of 7,763 million yen and 8,314 million yen, respectively. The company maintained a consistent annual dividend of 100 yen per share, despite the decline in net income. Looking ahead to the fiscal year ending March 31, 2026, the company projects a robust recovery and expansion. Forecasts indicate a 17.2% increase in net sales to 64,764 million yen and a substantial 95.0% growth in profit attributable to owners of the parent, reaching 3,815 million yen. These projections are based on information available as of April 2025 and remain subject to change based on future market conditions. The reporting period covers the Japanese fiscal year, and the results were prepared in accordance with Japanese GAAP.
Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepancy between this translated document and the Japanese original, the original shall prevail. April 30, 2025 Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (Under Japanese GAAP) Company name: Nagase Brothers Inc. Listing: Tokyo Stock Exchange Securities code: 9733 URL: https://www.toshin.com Representative: Akiyuki Nagase, President(CEO) Inquiries: Masao Utsumi, Managing Director, Division Head, General Affairs Division Telephone: +81‑0422‑45‑7011 Scheduled date of annual general meeting of shareholders: June 27, 2025 Scheduled date to commence dividend payments: June 30, 2025 Scheduled date to file annual securities report: June 26, 2025 Preparation of supplementary material on financial results: Yes Holding of financial results briefing: Yes (Yen amounts are rounded down to millions, unless otherwise noted.) Consolidated financial results for the fiscal year ended March 31, 2025 (from April 1, 2024 to March 31, 2025) (1) Consolidated operating results (Percentages indicate year‑on‑year changes.) Net sales Operating profit Ordinary profit Profit attributable to owners of parent Fiscal year ended Millions of yen % Millions of yen % Millions of yen % Millions of yen % March 31, 2025 55,255 4.3 4,864 7.2 3,879 (10.3) 1,956 (24.8) March 31, 2024 52,986 1.2 4,538 (15.5) 4,323 (14.8) 2,602 (35.0) Note: Comprehensive income For the fiscal year ended March 31, 2025: ¥5,038 million [1.8%] For the fiscal year ended March 31, 2024: ¥4,951 million [(2.7%)]
lions of yen % March 31, 2025 55,255 4.3 4,864 7.2 3,879 (10.3) 1,956 (24.8) March 31, 2024 52,986 1.2 4,538 (15.5) 4,323 (14.8) 2,602 (35.0) Note: Comprehensive income For the fiscal year ended March 31, 2025: ¥5,038 million [1.8%] For the fiscal year ended March 31, 2024: ¥4,951 million [(2.7%)] Basic earnings Diluted earnings Return on equity Ratio of ordinary Ratio of operating per share per share profit to total assets profit to net sales Fiscal year ended Yen Yen % % % March 31, 2025 74.33 - 6.5 4.3 8.8 March 31, 2024 98.84 - 9.4 5.2 8.6 Reference: Share of profit (loss) of entities accounted for using equity method For the fiscal year ended March 31, 2025: (¥695 million) For the fiscal year ended March 31, 2024: (¥30 million) (2) Consolidated financial position Total assets Net assets Equity‑to‑asset ratio Net assets per share As of Millions of yen Millions of yen % Yen March 31, 2025 90,107 31,172 34.6 1,184.10 March 31, 2024 88,286 28,766 32.6 1,092.70 Reference: Equity As of March 31, 2025: ¥31,172 million As of March 31, 2024: ¥28,766 million
(3) Consolidated cash flows Cash flows from Cash flows from Cash flows from Cash and cash operating activities investing activities financing activities equivalents at end of period Fiscal year ended Millions of yen Millions of yen Millions of yen Millions of yen March 31, 2025 8,183 (7,763) (8,314) 15,932 March 31, 2024 4,067 (1,953) 4,750 23,827 2. Cash dividends Annual dividends per share Total cash Payout ratio Ratio of First Second Third Fiscal dividends (Consolidated) dividends to quarter‑end quarter‑end quarter‑end year‑end Total (Total) net assets (Consolidated) Yen Yen Yen Yen Yen Millions of yen % % Fiscal year ended ‑ 0.00 ‑ 100.00 100.00 2,632 101.2 9.5 March 31, 2024 Fiscal year ended ‑ 0.00 ‑ 100.00 100.00 2,632 134.5 8.8 March 31, 2025 Fiscal year ending March 31, 2026 ‑ 0.00 ‑ 100.00 100.00 69.0 (Forecast) 3.Forecast of consolidated financial results for the fiscal year ended March 31, 2026 (from April 1, 2025 to March 31, 2026) (Percentages indicate year‑on‑year changes.) Net sales Operating profit Ordinary profit Profit attributable to Basic earnings owners of parent per share Millions of yen % Millions of yen % Millions of yen % Millions of yen % Yen Full year 64,764 17.2 6,526 34.1 6,373 64.3 3,815 95.0 144.91
* Notes (1) Significant changes in the scope of consolidation during the period: Yes Newly included: 1 company (ITOMAN SPORTS WELLNESS CO., LTD.) Excluded: 0 companies (2) Changes in accounting policies, changes in accounting estimates, and restatement (i) Changes in accounting policies due to revisions to accounting standards and other regulations: Yes (ii) Changes in accounting policies due to other reasons: None (iii) Changes in accounting estimates: None (iv) Restatement: None (3) Number of issued shares (common shares) (i) Total number of issued shares at the end of the period (including treasury shares) As of March 31, 2025 30,445,227 shares As of March 31, 2024 30,445,227 shares (ii) Number of treasury shares at the end of the period As of March 31, 2025 4,119,141 shares As of March 31, 2024 4,119,141 shares (iii) Average number of shares outstanding during the period Fiscal year ended March 31, 2025 26,326,086 shares Fiscal year ended March 31, 2024 26,326,086 shares [Reference] Overview of non-consolidated financial results Non-consolidated financial results for the fiscal year ended March 31, 2025 (from April 1, 2024 to March 31, 2025) (1) Non-consolidated operating results (Percentages indicate year‑on‑year changes.) Net sales Operating profit Ordinary profit Profit Fiscal year ended Millions of yen % Millions of yen % Millions of yen % Millions of yen % March 31, 2025 28,364 0.9 1,149 1.3 3,683 22.6 2,608 2.1 March 31, 2024 28,109 (4.4) 1,134 (42.0) 3,005 (16.0) 2,553 (30.3) Basic earnings Diluted earnings per share per share Fiscal year ended Yen Yen March 31, 2025 99.07 ‑ March 31, 2024 96.99 ‑ (2) Non-consolidated financial position
of yen % March 31, 2025 28,364 0.9 1,149 1.3 3,683 22.6 2,608 2.1 March 31, 2024 28,109 (4.4) 1,134 (42.0) 3,005 (16.0) 2,553 (30.3) Basic earnings Diluted earnings per share per share Fiscal year ended Yen Yen March 31, 2025 99.07 ‑ March 31, 2024 96.99 ‑ (2) Non-consolidated financial position Total assets Net assets Equity‑to‑asset ratio Net assets per share As of Millions of yen Millions of yen % Yen March 31, 2025 74,994 26,929 35.9 1,022.94 March 31, 2024 74,417 23,864 32.1 906.51 Reference: Equity As of March 31, 2025 ¥26,929 million As of March 31, 2024: ¥23,864 million
2. Forecast of non-consolidated financial results for the fiscal year ended March 31, 2025 (from April 1, 2024 to March 31, 2025) (Percentages indicate year‑on‑year changes.) Net sales Operating profit Profit attributable to Basic earnings owners of parent per share Millions of yen % Millions of yen % Millions of yen % yen Full year 31,379 10.6 4,811 30.6 3,900 49.5 148.14 * Financial results reports are exempt from audit conducted by certified public accountants or an audit firm. * Proper use of earnings forecasts, and other special matters The earnings forecasts and other forward‑looking statements herein are based on certain information available to us as of the date of publication of this document and on certain assumptions deemed reasonable. As such, actual results may differ significantly from these forecasts due to a wide range of factors.
France Bed Holdings Co., Ltd. released its consolidated financial results for the six-month period ending September 30, 2025, prepared in accordance with Japanese GAAP. The report details the company’s operating performance, financial position, and cash flow status, while maintaining its previously announced earnings forecasts for the full fiscal year ending March 31, 2026. During the first half of the fiscal year, the company reported net sales of 29,259 million yen, remaining essentially flat compared to the same period in the previous year. However, profitability metrics experienced a decline, with operating profit falling 16.0% to 1,782 million yen and ordinary profit decreasing 17.7% to 1,765 million yen. Profit attributable to owners of the parent reached 1,047 million yen, representing a 20.9% year-on-year decline. Basic earnings per share for the period were 31.20 yen, down from 38.36 yen in the prior year. The company’s financial position as of September 30, 2025, shows total assets of 67,084 million yen and net assets of 39,158 million yen, resulting in an equity-to-asset ratio of 58.3%. Cash flows from operating activities provided 2,541 million yen, while investing and financing activities reflected ongoing capital allocation, including the purchase of treasury shares and continued investment in property, plant, and equipment. Looking ahead to the full fiscal year ending March 31, 2026, the company maintains its forecast of 62,300 million yen in net sales and 4,750 million yen in operating profit. These projections reflect a modest growth expectation of 2.8% in sales and 1.1% in operating profit compared to the previous fiscal year. The company continues to operate under stable accounting policies with no significant changes in the scope of consolidation.
TOWA Corporation’s consolidated financial results for the nine months ended December 31, 2025, reflect a challenging period characterized by a year-on-year decline in both revenue and profitability. Net sales reached 36,930 million yen, representing a 5.9% decrease compared to the same period in the previous year. Operating profit fell significantly by 43.5% to 3,685 million yen, while profit attributable to owners of the parent declined by 49.0% to 2,627 million yen. These results were primarily driven by a shift in product mix, increased development costs, and the adverse impacts of U.S. tariff policies and sluggish demand within the automotive semiconductor sector. The company operates across three primary segments: Semiconductor Manufacturing Equipment, Medical Device, and Laser Processing Machine. The Semiconductor Manufacturing Equipment business, which constitutes the majority of total sales, saw a 6.0% decline in revenue to 33,940 million yen. While the Medical Device segment experienced a modest revenue increase of 7.8%, the Laser Processing Machine business faced a 20.0% decline in sales and an operating loss of 86 million yen. Despite these headwinds, the company reported a strong order environment, particularly for AI and data center-related memory applications, with third-quarter orders reaching their second-highest level on record. As of December 31, 2025, the company’s financial position remains stable with total assets of 101,357 million yen and an equity-to-asset ratio of 66.6%. Looking ahead, the company has revised its full-year forecasts downward due to delayed revenue recognition from mass production investments and higher costs associated with initial shipments. However, management anticipates a recovery trend, supported by a robust order backlog and expected improvements in product mix as demand for compression equipment grows.
TOWA CORPORATION’s consolidated financial results for the six months ended September 30, 2025, reflect a period of significant year-on-year decline in both revenue and profitability. The company reported net sales of 23,449 million yen, a 14.4% decrease compared to the same period in the previous fiscal year. Operating profit fell by 52.6% to 2,493 million yen, while profit attributable to owners of the parent dropped 51.7% to 1,849 million yen. These results were primarily driven by a slowdown in orders that began in the second half of the previous fiscal year, stemming from weak demand in consumer and memory semiconductor markets and the impact of international tariff policies. The semiconductor manufacturing equipment business, which represents the company’s primary segment, saw net sales decline by 14.7% to 21,585 million yen, with operating profit falling 53.6%. The laser processing machine business also struggled, reporting an operating loss of 82 million yen. Conversely, the medical device business showed resilience, achieving an 8.4% increase in net sales to 1,224 million yen. Despite the overall downturn, the company noted a gradual recovery in capital investment during the second quarter, particularly in China, Taiwan, and other Asian markets, which helped profits exceed initial internal expectations. As of September 30, 2025, the company maintained a solid financial position with total assets of 91,013 million yen and an equity-to-asset ratio of 70.1%. Given the ongoing market uncertainties and fluctuating customer investment trends, the company has opted to maintain its previously announced full-year earnings forecast for the fiscal year ending March 31, 2026, which projects net sales of 56,000 million yen and an operating profit of 9,800 million yen.
TOWA CORPORATION’s consolidated financial results for the first quarter ended June 30, 2025, reflect a period of significant contraction compared to the same period in the previous fiscal year. The company reported net sales of 8,080 million yen, representing a 39.0% year-on-year decline. Profitability metrics also shifted into negative territory, with an operating loss of 581 million yen, an ordinary loss of 732 million yen, and a loss attributable to owners of the parent of 528 million yen. This performance stands in stark contrast to the first quarter of 2024, which saw an operating profit of 2,212 million yen. The primary driver of this downturn was the semiconductor manufacturing equipment business, which experienced a 41.2% decrease in net sales, resulting in an operating loss of 607 million yen. Management attributes this decline to heightened uncertainty regarding U.S. tariff policies, which prompted customers to adopt a cautious approach to capital investment and led to the rescheduling of equipment deliveries. While the medical device business maintained steady performance with a 4.3% increase in net sales, the laser processing machine business also saw a decline, with net sales falling 33.2% year-on-year. Despite these results, the company maintains a neutral outlook for the remainder of the fiscal year. Management reports that the order environment is showing signs of recovery, particularly in China, and notes that the customer base for its generative AI-related molding equipment is expanding. Consequently, the company has not revised its previously announced consolidated earnings forecasts for the second quarter or the full fiscal year, anticipating a return to profitability as capital investment and demand recover across key Asian markets.